GLAUKOS CORPORATION Financials Glaukos Corporation
Equities
GKOS
US3773221029
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.48 USD | -0.63% |
|
+3.09% | +25.15% |
| Apr. 11 | Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating | MT |
| Apr. 11 | Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,011 | 3,382 | 2,083 | 2,082 | 3,877 | 4,990 | - | - |
| Enterprise Value (EV) 1 | 1,837 | 3,227 | 2,021 | 2,082 | 3,935 | 5,166 | 5,136 | 4,940 |
| P/E ratio | 147 x | -27.9 x | -41.5 x | -20.9 x | -28.6 x | -42.3 x | -63.5 x | -90.3 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 8.49 x | 15 x | 7.08 x | 7.36 x | 12.3 x | 14 x | 11.2 x | 8.89 x |
| EV / Revenue | 7.75 x | 14.3 x | 6.87 x | 7.36 x | 12.5 x | 14.5 x | 11.5 x | 8.8 x |
| EV / EBITDA | -41.8 x | -34.3 x | 258 x | -37.8 x | -56.1 x | -69 x | -117 x | 185 x |
| EV / FCF | -361 x | -108 x | -87.6 x | -32.9 x | -50.4 x | -132 x | -71.6 x | -235 x |
| FCF Yield | -0.28% | -0.93% | -1.14% | -3.04% | -1.98% | -0.76% | -1.4% | -0.43% |
| Price to Book | 3.52 x | 5.1 x | 3.55 x | 3.94 x | 8.46 x | 10.4 x | 9.53 x | 5.74 x |
| Nbr of stocks (in thousands) | 36,917 | 44,933 | 46,862 | 47,675 | 48,772 | 50,160 | - | - |
| Reference price 2 | 54.47 | 75.26 | 44.44 | 43.68 | 79.49 | 99.48 | 99.48 | 99.48 |
| Announcement Date | 2/27/20 | 2/25/21 | 2/22/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 237 | 225 | 294 | 282.9 | 314.7 | 356.7 | 445.2 | 561.3 |
| EBITDA 1 | -43.99 | -94.17 | 7.825 | -55.13 | -70.13 | -74.9 | -43.95 | 26.63 |
| EBIT 1 | -50.29 | -48.21 | -21.84 | -86.7 | -103.8 | -98.3 | -62.25 | -17.59 |
| Operating Margin | -21.22% | -21.43% | -7.43% | -30.65% | -32.98% | -27.56% | -13.98% | -3.13% |
| Earnings before Tax (EBT) 1 | -50.04 | -132.3 | - | - | -133.7 | -105 | -70.69 | -28.97 |
| Net income 1 | 15.42 | -120.3 | -49.59 | -99.2 | -134.7 | -113 | -74.13 | -54.88 |
| Net margin | 6.51% | -53.5% | -16.87% | -35.07% | -42.79% | -31.67% | -16.65% | -9.78% |
| EPS 2 | 0.3700 | -2.700 | -1.070 | -2.090 | -2.780 | -2.350 | -1.568 | -1.102 |
| Free Cash Flow 1 | -5.093 | -29.92 | -23.08 | -63.35 | -78.01 | -39.17 | -71.7 | -21 |
| FCF margin | -2.15% | -13.3% | -7.85% | -22.4% | -24.79% | -10.98% | -16.11% | -3.74% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 2/25/21 | 2/22/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 74.71 | 73.24 | 67.68 | 72.68 | 71.27 | 71.23 | 73.9 | 80.4 | 78.05 | 82.36 | 79.66 | 87.53 | 89.94 | 99.84 | 97.97 |
| EBITDA 1 | 18.41 | -2.813 | -6.028 | -21.1 | -7.394 | -19.24 | -18.46 | -12.98 | -13.33 | -23.88 | -21.68 | -17.17 | -16.72 | -18.72 | -15.2 |
| EBIT 1 | -4.859 | -10.32 | -13.64 | -30.36 | -15.29 | -27.42 | -26.76 | -22.85 | -21.78 | -32.39 | -27.42 | -23.53 | -22.99 | -23.78 | -20.91 |
| Operating Margin | -6.5% | -14.08% | -20.15% | -41.77% | -21.45% | -38.5% | -36.22% | -28.42% | -27.91% | -39.33% | -34.41% | -26.88% | -25.57% | -23.82% | -21.34% |
| Earnings before Tax (EBT) 1 | 6.432 | -22.24 | 5.703 | -45.64 | -27.33 | -31.16 | -34.22 | -32.38 | -30.41 | -36.72 | -29.78 | -25.51 | -24.94 | -24.8 | -25.35 |
| Net income 1 | 6.23 | -21.87 | 5.377 | -45.54 | -27.58 | -31.46 | -34.63 | -32.81 | -30.44 | -36.78 | -31.29 | -27.37 | -26.96 | -27.3 | -23.55 |
| Net margin | 8.34% | -29.86% | 7.94% | -62.65% | -38.69% | -44.17% | -46.86% | -40.81% | -39.01% | -44.65% | -39.27% | -31.27% | -29.98% | -27.35% | -24.04% |
| EPS 2 | 0.1300 | -0.4700 | 0.1100 | -0.9600 | -0.5800 | -0.6600 | -0.7200 | -0.6800 | -0.6300 | -0.7500 | -0.6538 | -0.5729 | -0.5550 | -0.5862 | -0.5300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/22/22 | 5/4/22 | 8/3/22 | 11/2/22 | 2/22/23 | 5/3/23 | 8/2/23 | 11/1/23 | 2/21/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 57.9 | 176 | 146 | - |
| Net Cash position 1 | 174 | 154 | 61.3 | - | - | - | - | 49.8 |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.8253 x | -2.346 x | -3.324 x | - |
| Free Cash Flow 1 | -5.09 | -29.9 | -23.1 | -63.3 | -78 | -39.2 | -71.7 | -21 |
| ROE (net income / shareholders' equity) | 3.64% | -7.62% | -6.15% | -18.5% | -22.1% | -24.2% | -12.6% | 1.23% |
| ROA (Net income/ Total Assets) | 3.01% | -5.6% | -3.75% | -10.1% | -11.3% | -11.4% | -1.09% | 4.72% |
| Assets 1 | 512.7 | 2,149 | 1,322 | 982.5 | 1,192 | 989.2 | 6,826 | -1,162 |
| Book Value Per Share 2 | 15.50 | 14.80 | 12.50 | 11.10 | 9.400 | 9.540 | 10.40 | 17.30 |
| Cash Flow per Share | -0.0100 | -0.5200 | - | - | - | - | - | - |
| Capex 1 | 4.72 | 6.94 | 47.8 | 30.3 | 20.2 | 22 | 23.8 | 26.8 |
| Capex / Sales | 1.99% | 3.08% | 16.25% | 10.7% | 6.43% | 6.17% | 5.35% | 4.77% |
| Announcement Date | 2/27/20 | 2/25/21 | 2/22/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
99.48
USD
Average target price
106.6
USD
Spread / Average Target
+7.20%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.15% | 4.99B | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B | |
| -22.81% | 1.79B |
- Stock Market
- Equities
- GKOS Stock
- Financials Glaukos Corporation
